Cardiovascular Effects of DPP-4 Inhibitors Tied to Metformin Use Cardiovascular Effects of DPP-4 Inhibitors Tied to Metformin Use

Concomitant metformin use is associated with cardiovascular outcomes of the use of dipeptidyl peptidase 4 (DPP-4) inhibitors, according to a meta-analysis of three clinical trials.Reuters Health Information

Source: Medscape Medical News Headlines - November 27, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news